UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
January 10, 2005
PROXYMED, INC.
| Florida | 000-22052 | 65-0202059 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 1854 Shackleford Court, Suite 200, Atlanta, Georgia | 30093-2924 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code (770) 806-9918
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02. Departure of Directors of Principal Officers; Election of Directors; Appointment of Principal Officers
On January 10, 2005, ProxyMed, Inc. (the “Company”) accepted the resignation of Michael K. Hoover, Chief Executive Officer of the Company to be effective January 31, 2005 and appointed Kevin M. McNamara the Company Chairman of the Board, interim CEO. The Company is evaluating internal and external candidates for permanent CEO. A copy of the Company’s press release is attached as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
Exhibits
As described in Item 5.02 of this Report, the following Exhibit is furnished as part of this Current Report on Form 8-K.
| Exhibit No. | Description | |||
| 99.1 | Press release of the Company dated January 11, 2005. |
|||
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ProxyMed, Inc. |
||||
| Date: January 10, 2005 | /s/ Gregory J. Eisenhauer | |||
| Gregory J. Eisenhauer, C.F.A., | ||||
| Executive Vice President and Chief Financial Officer | ||||
3